Table 3.
Regression models.
| Univariate regression model |
OR | 95% CI | P value |
|---|---|---|---|
| Age | 0.977 | 0.930-1.026 | 0.354 |
| Gender | 0.463 | 0.155-1.382 | 0.168 |
| BMI | 0.901 | 0.778-1.402 | 0.159 |
| Hypertension | 1.089 | 0.414-2.863 | 0.863 |
| Diabetes | 1.179 | 0.486-2.860 | 0.716 |
| Hyperlipidemia | 1.214 | 0.429-3.438 | 0.715 |
| COPD | 1.472 | 0.089-24.306 | 0.787 |
| Stenosis vessel number | 0.770 | 0.434-1.376 | 0.373 |
| History of angina | 1.476 | 0.499-4.366 | 0.481 |
| NYHA | 1.716 | 1.137-2.588 | 0.010 |
| QRS duration | 1.030 | 1.002-1.059 | 0.034 |
| LVEDV | 1.029 | 1.015-1.043 | 0.000 |
| Hibernating myocardium | 1.171 | 1.085-1.264 | 0.000 |
| Scar | 1.129 | 1.049-1.214 | 0.001 |
| Multivariate regression model | |||
| NYHA | 1.482 | 0.899-2.441 | 0.123 |
| QRS duration | 1.010 | 0.969-1.054 | 0.632 |
| LVEDV | 1.014 | 1.000-1.030 | 0.058 |
| HM | 1.110 | 1.029-1.197 | 0.007 |
| Scar | 1.042 | 0.955-1.137 | 0.351 |
BMI, body mass index; NYHA, New York Heart Association classification of heart failure; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end diastolic volume, HM, hibernating myocardium.